Seeking Alpha

U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems

ABBOTT PARK, Ill., March 6, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has cleared its FreeStyle Libre 2 and FreeStyle Libre 3 integrated ...
Pharmabiz

Tandem Diabetes Care’s t:slim X2 insulin delivery system to integrate with Abbott’s new FreeStyle Libra 2 plus sensor insulin pump

Abbott, the global health care company, and Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that the t:slim X2 insulin pump with Control-IQ technology ...